Death by diabetes: lessons for underwriters.

Today, more than ever, finding less invasive ways to underwrite impairments efficiently and effectively is of vital importance. New research on reliable mortality and morbidity indicators for diabetes offers important clues.

Genetic Kidney Disease

DNA dilemma

While there’s no cure for polycystic kidney disease, genetic screening could provide a path forward. Explore questions and underwriting considerations in OTR.